193
Modeling
oxygen transport, tissues, 98
Monocyte chemoattractant protein-1
(MCP-1), 56
Morrissette-McAlmon, J., 141–166
Mouse embryonic fibroblasts (MEFs), 135
Multiphoton polymerization (MMP), 133
Mural cells, 144, 150, 151
Myocardial infarctions (MI)
ischemic settings, 157
N
NADPH oxidases (NOXs), 81
Neonatal cardiac fibroblasts (nCF), 151
Neonatal rat ventricular cardiomyocytes
(NRVCMs), 144, 149, 156, 157,
161, 162
Neotissue formation, 133
Nih, L.R., 184
Nishiyama, Y., 125
Normal human lung fibroblast (NHIF), 126
Norrette, C., 134
O
Ong, C.S., 121–137, 158
Oshikawa, M., 181
P
Papandreou, I., 83
Parmar, K., 78
Penumbra, 178, 179
Perfluorocarbons (PFCs), 105
Photoelastomers, 132
Piezoelectric systems, 122
Pig articular chondrocytes (PACs), 134
Pitrez, P.R., 51–66
Placental growth factor (PLGF), 82
Plateau-Rayleigh instability, 122
Platelet-derived growth factor (PDGF), 43,
82, 91
Poly L-lactic acid (PLLA), 158
Poly(ethylene glycol) (PEG), 129
Poly(ethylene oxide) (PEO), 129
Poly(lactic-co-glycolic) acid (PLGA), 181
Poly(L-lactide-co-ε-caprolactone) (PLCL), 130
Poly(propylene fumarate) (PPF), 133
Polycaprolactone (PCL), 93
Polycrystalline, 122
Polydimethylsiloxane (PDMS), 63
Polydimethylsiloxane-tetraethoxysilane
(PDMS-TEOS), 181
Polyglycolic acid (PGA), 43, 130
Polylactic-glycolic acid (PLGA),
152, 158
Poly-L-lactic acid (PLLA), 152
Polytetrahydrofuran-diacrylate (PTHF-DA), 133
Porcine aortic smooth muscle cells
(PASMCs), 134
Prado-Lopez, S., 84
Prasad, S.M., 84
Pro-angiogenic regenerative therapies
American Heart Association, 177
brain angiogenesis, 178–182
endogenous angiogenesis, 179
long-term studies, 183
macro- and microarchitecture, 183
neurovascular damage after stroke, 178
preclinical studies, 177
VEGF-based therapeutic approach, 180
Progerin, 52, 58, 61, 62, 65
Prolyl hydroxylase domain (PHD), 80
Pyrophosphate (PPi), 61
R
Radisic, M., 105
Rat aortic endothelial cells (rAEC), 151
Rat heart endothelial cells (RHECs), 128
Reinhart-King, C.A., 40
Rho-associated kinase (ROCK), 43
Rita Sá Ferreira, 51–66
Rosenfeld, D., 42
S
Scaffold-free 3D printing
microvascular network creation, 134
principle, 133
vascular graft creation, 134, 135
Schaefer, J.A., 152
Segura, I., 102
Segura, T., 179
Senescence-associated secretory phenotype
(SASP), 61
Shape memory effect (SME), 133
Shen, Y.H., 103
Siallagan, D., 136
Sirtuins, 52
Small GTPases, 6, 10–11, 15
Smooth muscle cells (SMCs), 53–55, 57, 58,
61–63, 65, 66, 126
Snyder, S., 141–166
Stem cell factor (SCF), 10, 28, 29
Stereolithography processing (SL), 133
Stevens, K.R., 157
Index
Modeling
oxygen transport, tissues, 98
Monocyte chemoattractant protein-1
(MCP-1), 56
Morrissette-McAlmon, J., 141–166
Mouse embryonic fibroblasts (MEFs), 135
Multiphoton polymerization (MMP), 133
Mural cells, 144, 150, 151
Myocardial infarctions (MI)
ischemic settings, 157
N
NADPH oxidases (NOXs), 81
Neonatal cardiac fibroblasts (nCF), 151
Neonatal rat ventricular cardiomyocytes
(NRVCMs), 144, 149, 156, 157,
161, 162
Neotissue formation, 133
Nih, L.R., 184
Nishiyama, Y., 125
Normal human lung fibroblast (NHIF), 126
Norrette, C., 134
O
Ong, C.S., 121–137, 158
Oshikawa, M., 181
P
Papandreou, I., 83
Parmar, K., 78
Penumbra, 178, 179
Perfluorocarbons (PFCs), 105
Photoelastomers, 132
Piezoelectric systems, 122
Pig articular chondrocytes (PACs), 134
Pitrez, P.R., 51–66
Placental growth factor (PLGF), 82
Plateau-Rayleigh instability, 122
Platelet-derived growth factor (PDGF), 43,
82, 91
Poly L-lactic acid (PLLA), 158
Poly(ethylene glycol) (PEG), 129
Poly(ethylene oxide) (PEO), 129
Poly(lactic-co-glycolic) acid (PLGA), 181
Poly(L-lactide-co-ε-caprolactone) (PLCL), 130
Poly(propylene fumarate) (PPF), 133
Polycaprolactone (PCL), 93
Polycrystalline, 122
Polydimethylsiloxane (PDMS), 63
Polydimethylsiloxane-tetraethoxysilane
(PDMS-TEOS), 181
Polyglycolic acid (PGA), 43, 130
Polylactic-glycolic acid (PLGA),
152, 158
Poly-L-lactic acid (PLLA), 152
Polytetrahydrofuran-diacrylate (PTHF-DA), 133
Porcine aortic smooth muscle cells
(PASMCs), 134
Prado-Lopez, S., 84
Prasad, S.M., 84
Pro-angiogenic regenerative therapies
American Heart Association, 177
brain angiogenesis, 178–182
endogenous angiogenesis, 179
long-term studies, 183
macro- and microarchitecture, 183
neurovascular damage after stroke, 178
preclinical studies, 177
VEGF-based therapeutic approach, 180
Progerin, 52, 58, 61, 62, 65
Prolyl hydroxylase domain (PHD), 80
Pyrophosphate (PPi), 61
R
Radisic, M., 105
Rat aortic endothelial cells (rAEC), 151
Rat heart endothelial cells (RHECs), 128
Reinhart-King, C.A., 40
Rho-associated kinase (ROCK), 43
Rita Sá Ferreira, 51–66
Rosenfeld, D., 42
S
Scaffold-free 3D printing
microvascular network creation, 134
principle, 133
vascular graft creation, 134, 135
Schaefer, J.A., 152
Segura, I., 102
Segura, T., 179
Senescence-associated secretory phenotype
(SASP), 61
Shape memory effect (SME), 133
Shen, Y.H., 103
Siallagan, D., 136
Sirtuins, 52
Small GTPases, 6, 10–11, 15
Smooth muscle cells (SMCs), 53–55, 57, 58,
61–63, 65, 66, 126
Snyder, S., 141–166
Stem cell factor (SCF), 10, 28, 29
Stereolithography processing (SL), 133
Stevens, K.R., 157
Index